The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These Cancers

Giorgio Gandaglia, Alberto Briganti, Nicola Fossati, Andrea Salonia, Alexandre Mottrie, James Catto, Francesco Montorsi

Research output: Contribution to journalArticle

Abstract

One of the most effective ways to reduce overtreatment of prostate cancer is to limit its detection in men with low-risk disease. Although many data are currently missing, we foresee a future with reduced prostate-specific antigen (PSA) testing in men selected through baseline PSA values or genetic predisposition. Then selective biopsy using multiparametric magnetic resonance imaging and longitudinal biomarkers will play a role.

Original languageEnglish
JournalEuropean Urology
DOIs
Publication statusAccepted/In press - 2016

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These Cancers'. Together they form a unique fingerprint.

  • Cite this